» Articles » PMID: 9330554

Use of the MQoL-HIV with Asymptomatic HIV-positive Patients

Overview
Journal Qual Life Res
Date 1997 Aug 1
PMID 9330554
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine the appropriateness of the recently developed Multidimensional Quality of Life Questionnaire for HIV/AIDS (MQoL-HIV) as a measure of quality of life (QoL) in cases of asymptomatic human immunodeficiency virus (HIV) infection. The MQoL-HIV is a 40-item instrument measuring ten domains (mental health, physical health, physical functioning, social functioning, social support, cognitive functioning, financial status, partner intimacy, sexual functioning and medical care) relevant to HIV infection. An overall QoL score, the MQoL-HIV Index, is a weighted composite of two domain scores. In a sample of 216 HIV-infected men and women, the MQoL-HIV distinguished acquired immune deficiency syndrome (AIDS), symptomatic and asymptomatic cases in overall QoL and in seven individual QoL domains. The index was responsive to perceived QoL changes over 5.5 months (r = 0.52). We also found the MQoL-HIV was less susceptible to ceiling effects in asymptomatic cases than was the Medical Outcomes Study (MOS) SF-20. These results suggest that the MQoL-HIV is a valid and reliable measure of QoL for both asymptomatic and symptomatic HIV infection.

Citing Articles

Health-related quality of life measures provide information on the contributors, components, and consequences of frailty in HIV: a systematic mapping review.

Inceer M, Mayo N Qual Life Res. 2024; 33(7):1735-1751.

PMID: 38462582 DOI: 10.1007/s11136-024-03613-3.


HIV-Specific Reported Outcome Measures: Systematic Review of Psychometric Properties.

Wang Z, Zhu Y, Duan X, Kang H, Qu B JMIR Public Health Surveill. 2022; 8(12):e39015.

PMID: 36222289 PMC: 9782451. DOI: 10.2196/39015.


"A fog that impacts everything": a qualitative study of health-related quality of life in people living with HIV who have cognitive impairment.

Alford K, Daley S, Banerjee S, Hamlyn E, Trotman D, Vera J Qual Life Res. 2022; 31(10):3019-3030.

PMID: 35579729 PMC: 9470604. DOI: 10.1007/s11136-022-03150-x.


Psychometric properties of self-reported measures of health-related quality of life in people living with HIV: a systematic review.

Wen H, Yang Z, Zhu Z, Han S, Zhang L, Hu Y Health Qual Life Outcomes. 2022; 20(1):5.

PMID: 35012574 PMC: 8744327. DOI: 10.1186/s12955-021-01910-w.


Measuring quality of life among people living with HIV: a systematic review of reviews.

Cooper V, Clatworthy J, Harding R, Whetham J Health Qual Life Outcomes. 2017; 15(1):220.

PMID: 29141645 PMC: 5688651. DOI: 10.1186/s12955-017-0778-6.


References
1.
Kazis L, Anderson J, Meenan R . Effect sizes for interpreting changes in health status. Med Care. 1989; 27(3 Suppl):S178-89. DOI: 10.1097/00005650-198903001-00015. View

2.
Ho D . Time to hit HIV, early and hard. N Engl J Med. 1995; 333(7):450-1. DOI: 10.1056/NEJM199508173330710. View

3.
Holmes W, Bix B, Shea J . SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Med Care. 1996; 34(6):562-9. DOI: 10.1097/00005650-199606000-00006. View

4.
Whalen C, Antani M, Carey J, Landefeld C . An index of symptoms for infection with human immunodeficiency virus: reliability and validity. J Clin Epidemiol. 1994; 47(5):537-46. DOI: 10.1016/0895-4356(94)90300-x. View

5.
CARPENTER C, Fischl M, Hammer S, Hirsch M, Jacobsen D, Katzenstein D . Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA. 1996; 276(2):146-54. View